Brussels-based NGO bringing mothers' and families' civil society perspective to EU health and sustainability research consortia.
Make Mothers Matter EU Delegation is the Brussels-based European office of an international NGO that advocates for mothers, families, and children in EU policy. In research consortia, they contribute civil society representation, patient community engagement, and public dissemination — ensuring that research outputs reach families, policymakers, and the wider public rather than staying confined to academic circles. Their participation in SPIOMET4HEALTH brings the perspective of affected women and families into clinical research on polycystic ovary syndrome in adolescent girls, while their earlier CIRC4Life role channelled family and consumer perspectives into circular economy product design. As an EU-level advocacy body with access to EU institutions in Brussels, they are particularly valuable when a consortium needs to demonstrate societal impact or engage non-specialist audiences.
Active participant in SPIOMET4HEALTH (2021–2026), a clinical research project on PCOS treatment in adolescent girls and young women, where they bring patient community and family perspectives.
Present in both CIRC4Life and SPIOMET4HEALTH as a non-research participant, indicating a recurring role in reaching lay audiences and communicating research to families and policymakers.
Participated in CIRC4Life (2018–2021), a circular economy project focused on product and service lifecycles, likely representing family and consumer interests in sustainable design.
As a Brussels-based EU Delegation of an international NGO, they provide direct proximity to EU institutions — a structural asset for any consortium targeting policy uptake.
Their first H2020 project (CIRC4Life, 2018–2021) placed them in the sustainability and circular economy space — no specific health keywords appear for that period, suggesting a broad consumer and family advocacy role. Their second project (SPIOMET4HEALTH, 2021–2026) marks a sharp pivot toward women's reproductive health, with highly specific clinical keywords: PCOS, androgen excess, ectopic fat, anovulation, and named pharmaceutical treatments (pioglitazone, spironolactone, metformin). The trajectory shows a narrowing from general family-consumer advocacy toward a specialised focus on women's health conditions affecting mothers and young women.
They are moving toward becoming a specialist civil society voice in women's and adolescent reproductive health research, making them a strong dissemination and patient-engagement partner for future health consortia targeting hormonal or metabolic conditions in women.
Make Mothers Matter EU Delegation participates exclusively as a consortium partner — they have never coordinated an H2020 project. Their two projects spanned moderately large consortia (35 unique partners across 14 countries), suggesting they are comfortable operating within diverse multi-partner teams. Their role is not technical leadership but rather civil society contribution: community engagement, dissemination to families, and policy interface — the kind of partner a research consortium adds to satisfy societal impact requirements or patient-community engagement criteria.
Over two projects they have worked with 35 unique partners spread across 14 countries, a notably wide network for an organisation of this size and type. Their Brussels location gives them natural access to European-level policy and advocacy networks beyond the research consortia themselves.
Few NGOs operating at the EU level combine a family-advocacy mandate with active participation in both environmental and clinical health research consortia — this breadth makes them unusual among civil society organisations in H2020. For a health research consortium that needs a patient or community organisation with EU institutional access and no competing commercial interests, they fill a gap that universities and companies cannot. Their shift toward PCOS and adolescent women's health also positions them as a trusted voice for a patient population that is underrepresented in EU research advocacy.
